To conclude, the present study conducted in communitydwelling
elderly subjects in the setting of primary prevention
suggests the presence of some heterogeneity regarding the association
of lipids and apolipoproteins with CHD risk according to
lipid-lowering treatment received. In the absence of lipid-lowering
treatment, standard lipids, non-HDL cholesterol and apolipoprotein
B100 are independent predictors of CHD. In those under statins,
these associations remain and appear stronger. In those under
fibrates, only triglycerides and not LDL-cholesterol are the sole
independent predictors of CHD